The latest shareholding disclosures for Hong Kong-listed companies were released on August 20, 2026, highlighting significant changes in major shareholders' positions.

According to the filings, 银诺医药-B (02591) saw notable adjustments in its shareholder structure. 黄荔 reduced their long position from 40.6211 million shares to 38.6111 million shares, bringing their holding ratio down to 9.19% from the previous 9.67%. Similarly, 郑伟鹤 also decreased their stake to 38.6111 million shares, reflecting the same percentage change from 9.67% to 9.19%.

In parallel, multiple entities under the Cowin Capital umbrella have trimmed their holdings in 银诺医药-B (02591). Cowin China Growth Fund II, L.P., Cowin Capital Investment Limited, Cowin Capital Investment III Limited, and Cowin Capital Investment II LTD each reduced their long positions from 26.5564 million shares to 25.0164 million shares, lowering their respective stake from 6.32% to 5.95%.

It is important to note that fluctuations in share counts may arise from corporate actions such as rights issues, share consolidations, or stock splits. Investors should carefully cross-reference these figures with actual corporate events to ensure accuracy.